2.58 USD
▲+0.02+0.78%
盘后 3.08 0.00%
2026-11-06
市值
$109.95M
市盈率
—
EPS
-1.01
股息率
—
52 周区间
1.13 – 3.25
成交量
308.54K
Beta
0.17
目标价
3.70
52W 低 1.1352W 高 3.25
价格走势
公司简介
Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also offers LungTraX Platform, a cloud-based quantitative computed tomography analysis service that provides physicians with mult...